Mass Balance Study of [14C]JAB-21822

Clinical trial NCT05920941 · COMPLETED

Trial details

NCT number: NCT05920941
Sponsor: Allist Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mass Balance Study in Healthy Subjects

Start date: 2023-07-08
Primary completion: 2023-08-09
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.